Thyroid Disease and PCOS: The Overlap Most People Miss

Hashimoto's and PCOS overlap far more often than chance — autoimmune thyroid disease is roughly two to three times more common in women with PCOS. Their symptoms look almost identical, so it is easy to treat one and miss the other. The fix is to test for both and treat each on its own track.

The bidirectional link

Polycystic ovary syndrome (PCOS) affects an estimated 8–13% of reproductive-age women, and autoimmune thyroid disease is the most common autoimmune condition in this same group. The overlap is not subtle. A 2022 systematic review and meta-analysis by Hu and colleagues — pooling more than 9,000 women — found that the prevalence of Hashimoto's thyroiditis in women with PCOS was roughly two to three times higher than in matched controls, and that PCOS women carried significantly higher rates of TPO and Tg antibody positivity [C1]. A 2024 network meta-analysis extended the picture: autoimmune thyroid disorders broadly (Hashimoto's plus, less commonly, Graves') cluster with PCOS at rates well above background [C2].

The most rigorous look so far is a 2025 systematic review and meta-analysis by Kwiatkowski and colleagues that compared antibody rates while matching for TSH and BMI — controlling for the two biggest confounders. Even after that adjustment, women with PCOS still showed elevated TPO antibody prevalence, suggesting a real autoimmune signal rather than just a side effect of weight or thyroid status [C3].

Mechanically, this works both ways. Subclinical hypothyroidism can mimic PCOS (irregular cycles, weight gain, hair loss, infertility), and unrecognized PCOS — with its insulin resistance and inflammation — may help drive thyroid autoimmunity in genetically susceptible women [C4][C7].

Shared mechanisms

Four threads connect the two conditions [C4][C7]:

• Insulin resistance. Central to PCOS, and increasingly recognized in Hashimoto's even before frank hypothyroidism. Insulin lowers sex hormone-binding globulin (SHBG), which raises free androgens — the engine behind PCOS symptoms — and chronic hyperinsulinemia also pushes pro-inflammatory cytokines that can promote thyroid autoimmunity [C4].
• Low-grade chronic inflammation. Both conditions show elevated CRP, IL-6, and TNF-alpha. Oxidative stress and disrupted antioxidant defenses are documented in both, and one likely amplifies the other [C4].
• Androgens and SHBG. Hypothyroidism reduces SHBG, raising free testosterone, which can worsen PCOS features. Conversely, the metabolic environment of PCOS (high insulin, high androgens) is linked to higher rates of thyroid autoimmunity [C1][C7].
• Shared autoimmune susceptibility. Both conditions cluster with other autoimmune disease (vitiligo, celiac, type 1 diabetes) in the same families, pointing to overlapping genetic and immune risk [C2][C4].

How presentation overlaps

Because the two conditions share metabolic and hormonal pathways, their day-to-day symptoms are almost interchangeable. Anyone presenting with this cluster deserves a workup for both [C1][C7][C8]:

• Irregular or absent periods — classic PCOS, also a feature of overt hypothyroidism
• Difficulty losing weight or unexplained weight gain
• Fatigue and low energy
• Hair changes — diffuse scalp thinning (both conditions), facial hair (more PCOS), outer-eyebrow thinning (more thyroid)
• Acne — more typical of PCOS, but acne does flare with thyroid dysfunction
• Infertility or recurrent miscarriage — risk is increased in both, and stacked in women who have both [C5]
• Cold intolerance, dry skin, constipation — more thyroid-specific
• Mood symptoms — common in both

The clinical mistake is to anchor on one diagnosis and stop looking. A woman with new infertility and irregular cycles can easily be labeled "PCOS" without anyone checking TPO antibodies — and the reverse happens just as often.

What to test

A reasonable workup for any woman with this symptom cluster includes both axes [C6][C7][C8]:

Thyroid panel

• TSH (the primary screen)
• Free T4 (to characterize hypothyroidism)
• TPO antibodies (to identify Hashimoto's specifically)
• Tg antibodies and a thyroid ultrasound when antibodies are borderline or the gland is enlarged

PCOS workup

• Fasting insulin and glucose, plus HbA1c (insulin resistance)
• Total and free testosterone (androgens)
• SHBG (changes with both insulin and thyroid status)
• DHEA-S (adrenal androgens)
• LH/FSH ratio (less load-bearing than it used to be, but still ordered)
• Pelvic ultrasound (ovarian morphology)
• 17-OH progesterone if non-classical congenital adrenal hyperplasia is a possibility

Order both at the same time. Diagnosing one without the other locks in months of partial treatment.

Treatment implications

Levothyroxine fixes the thyroid side. It does not fix PCOS [C6].

For the thyroid side, the standard of care is levothyroxine when TSH is elevated and free T4 is low — or in subclinical hypothyroidism when fertility is on the table, TPO antibodies are positive, or symptoms are pronounced [C6][C8]. Doses are titrated to a TSH in the low-normal range (often 0.5–2.5 mIU/L when symptoms or fertility are involved). The thyroid antibodies themselves do not need to be "treated" — there is no medication that lowers TPO antibodies, and lowering them is not the goal.

For the PCOS side, treatment is tailored to what the patient wants. Common tools include lifestyle (weight, exercise, fiber, sleep), metformin or inositol for insulin resistance, combined hormonal contraception for cycle control and androgen reduction, anti-androgens (spironolactone) for hirsutism and acne, and GLP-1 receptor agonists when weight is the dominant driver. None of these are interchangeable with levothyroxine.

Pregnancy planning gets more complex. Both conditions independently increase the risk of miscarriage, gestational diabetes, and preterm birth, and the risks stack in women with both. The Trouva 2022 trial in pregnant women with PCOS showed that metformin during pregnancy was associated with a modest rise in TSH during pregnancy — a reminder that the two treatment tracks can interact and need to be co-managed [C5]. Pre-pregnancy TSH targets are stricter (often below 2.5 mIU/L), and Hashimoto's-positive women should be monitored more closely [C6].

What does NOT help

Several heavily-marketed approaches lack evidence for either condition and can make matters worse:

• "Endocrine balance" iodine megadoses or kelp supplements — can destabilize Hashimoto's and do nothing for PCOS [C8].
• Ashwagandha and other "adaptogenic" cocktails sold for both — limited PCOS evidence, documented thyrotoxicosis risk in Hashimoto's.
• Cortisol-lowering "adrenal fatigue" protocols — not a recognized diagnosis; do not address either underlying condition.
• One-pill "thyroid plus PCOS" multivitamin blends — usually contain iodine, biotin, and inositol at non-therapeutic doses; biotin distorts thyroid lab measurement.
• Skipping medication once labs improve — both conditions are chronic; symptoms returning means the underlying biology is still present [C6].

Practical guidelines

1. If you have one, screen for the other. Any woman with PCOS should have TSH, free T4, and TPO antibodies checked at diagnosis. Any woman with Hashimoto's plus irregular cycles, hirsutism, or infertility deserves a PCOS workup [C1][C2][C3][C7].
2. Treat each on its own track. Levothyroxine for thyroid, metformin or inositol or contraceptives or GLP-1 for PCOS. Neither replaces the other [C6].
3. Target TSH to symptom and fertility goals. Below 2.5 mIU/L is reasonable for women trying to conceive or with active symptoms [C6].
4. Address insulin resistance directly. It is the strongest shared driver of symptoms in women who have both [C4][C7].
5. Recheck thyroid labs every 6–8 weeks during dose changes — and any time pregnancy is planned or confirmed [C5][C6].
6. Don't chase TPO antibody titers. Their level does not match symptom severity, and there is no medication that lowers them directly [C6][C8].

Frequently asked questions

Does PCOS cause Hashimoto's? PCOS does not directly cause Hashimoto's, but they cluster together. The current evidence — including the TSH- and BMI-matched 2025 meta-analysis — suggests genuine shared autoimmune susceptibility, with insulin resistance and inflammation likely amplifying each [C1][C3][C4].

If I treat my hypothyroidism, will my PCOS get better? Treating hypothyroidism often improves cycle regularity and energy in women who were truly hypothyroid. It does not resolve the underlying PCOS — insulin resistance, hyperandrogenism, and ovarian morphology stay [C6].

Can subclinical hypothyroidism look like PCOS? Yes. Mild thyroid failure causes irregular cycles, weight gain, and hair changes that mirror PCOS. This is why TSH and TPO antibodies belong in any PCOS workup [C1][C7].

Is inositol useful for both conditions? Inositol (myo- and D-chiro-inositol) has the strongest evidence in PCOS for cycle regularity and insulin sensitivity. The evidence for inositol in Hashimoto's is much thinner. See our inositol-hashimotos article.

Does metformin affect thyroid hormone levels? Metformin can mildly lower TSH in some patients, and during pregnancy the Trouva 2022 trial showed a modest TSH-altering effect [C5]. Tell your endocrinologist if you are on metformin so they can interpret labs accordingly.

Bottom line

PCOS and Hashimoto's are two of the most common endocrine conditions in reproductive-age women, and they overlap far more than chance — autoimmune thyroid disease is roughly two to three times more prevalent in PCOS, and the link holds even after matching for TSH and BMI [C1][C2][C3]. They share insulin resistance, inflammation, and altered SHBG/androgen physiology, which makes their symptoms nearly identical [C4][C7]. The clinical answer is straightforward: test for both at the same time, treat each on its own track, and tighten thyroid control when pregnancy is on the table [C5][C6][C8].

Sources

1. [C1] Hu X et al. Correlation between Hashimoto's thyroiditis and polycystic ovary syndrome: A systematic review and meta-analysis. 2022. PubMed: 36387911
2. [C2] Bahreiny SS et al. Autoimmune thyroid disorders and polycystic ovary syndrome: Tracing links through systematic review and meta-analysis. 2024. PubMed: 38402811
3. [C3] Kwiatkowski J et al. Prevalence and Levels of Thyroid Autoantibodies in Polycystic Ovary Syndrome — Impact of TSH- and BMI-Matched Comparisons: A Systematic Review and Meta-Analysis. 2025. PubMed: 40806651
4. [C4] Batóg G et al. The interplay of oxidative stress and immune dysfunction in Hashimoto's thyroiditis and polycystic ovary syndrome: a comprehensive review. 2023. PubMed: 37588599
5. [C5] Trouva A et al. Thyroid Status During Pregnancy in Women With Polycystic Ovary Syndrome and the Effect of Metformin. 2022. PubMed: 35265033
6. [C6] Jonklaas J et al. Guidelines for the treatment of hypothyroidism. Thyroid. 2014;24(12):1670–1751. PubMed: 25266247
7. [C7] Mukherjee P et al. The Impact of Polycystic Ovary Syndrome (PCOS) on the Risk of Developing Ovarian Cancer and Thyroid Disorders: A Comprehensive Review. 2024. PubMed: 37986267
8. [C8] American Thyroid Association. Hypothyroidism — Patient Information. thyroid.org

---

For educational purposes only. Not medical advice. Always consult your healthcare provider.